Literature DB >> 11324438

Protective effect of bilobalide against nitric oxide-induced neurotoxicity in PC12 cells.

W Song1, H J Guan, X Z Zhu, Z L Chen, M L Yin, X F Cheng.   

Abstract

AIM: To examine the effects of bilobalide on nitric oxide-induced neurotoxicity in pheochromocytoma-derived PC12 cells (PC12 cells).
METHODS: PC12 cell survival was monitored by LDH release and 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assays. Superoxide dismutases (SOD) and catalase (CAT) activities were measured based on their abilities to inhibit the oxidation of epinephrine by the xanthine-xanthine oxidase system or to decompose H2O2 respectively. The content of malondialdehyde (MDA) was measured by a fluorometric assay to indicate the lipid peroxidation.
RESULTS: 3-Morpholinosydnonimine (SIN-1, 50-300 mumol.L-1) induced PC12 cell damage. After the cells had been pretreated with 10 mumol.L-1 bilobalide for 24 h, the cell viability was increased to 91% +/- 30% from 52% +/- 14% in SIN-1 alone group. Moreover, the activities of SOD and CAT were increased after cells were treated with bilobalide.
CONCLUSION: The NO-induced neurotoxicity can be protected by bilobalide in PC12 cells. The bilobalide-induced increase in SOD and CAT activities may serve as one of the mechanisms underlying the neuroprotective effect of bilobalide.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11324438

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  6 in total

1.  Effect of ultraviolet B (302 nm) irradiation on viability, metabolic and detoxification functions of goat hepatocytes--in vitro study.

Authors:  Naseem Begum Shakeel; Vijayalakshmi Venkateshan; Adarsh K Capoor; Mohammed Aejaz Habeeb; Ansar Ali Khan; Syed Muzeeb; N V S Rao Mamidi; Aleem Ahmed Khan; Chittoor Mohammed Habibullah
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

2.  Thioredoxin-1 was required for CREB activity by methamphetamine in rat pheochromocytoma cells.

Authors:  Tao Lv; Sheng-Dong Wang; Jie Bai
Journal:  Cell Mol Neurobiol       Date:  2012-12-13       Impact factor: 5.046

3.  CB1 as a novel target for Ginkgo biloba's terpene trilactone for controlling chemotherapy-induced peripheral neuropathy (CIPN).

Authors:  Farzaneh Samandar; Zeinab Amiri Tehranizadeh; Mohammad Reza Saberi; Jamshidkhan Chamani
Journal:  J Mol Model       Date:  2022-08-31       Impact factor: 2.172

Review 4.  Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders.

Authors:  Sandeep Kumar Singh; Saurabh Srivastav; Rudolph J Castellani; Germán Plascencia-Villa; George Perry
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

5.  Antiapoptotic Effects of EGb 761.

Authors:  Norma Serrano-García; José Pedraza-Chaverri; José Juan Mares-Sámano; Marisol Orozco-Ibarra; Arturo Cruz-Salgado; Anabel Jiménez-Anguiano; Julio Sotelo; Cristina Trejo-Solís
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-29       Impact factor: 2.629

6.  Synergistic Effects of Ginkgolide B and Protocatechuic Acid on the Treatment of Parkinson's Disease.

Authors:  Tingting Wu; Xianying Fang; Jiahui Xu; Yan Jiang; Fuliang Cao; Linguo Zhao
Journal:  Molecules       Date:  2020-08-31       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.